Unanimous Supreme Court Refines the Scope of Patent-ineligible Processes, Potentially Exposing Vulnerability of Patents in Life Science Technologies
Reproduced with permission from Life Sciences Law & Industry Report. Copyright © 2012 by The Bureau of National Affairs, Inc.
On March 20, the Supreme Court issued its widely anticipated decision in Mayo Collaborative Svcs. v. Prometheus Labs., Inc. (No. 10-1150). In a unanimous opinion, the Court invalidated claims of two patents that Prometheus asserted against Mayo, holding that the claimed methods cover laws of nature and fail the patent-eligibility requirements of 35 U.S.C. § 101.
This article first reviews the Mayo decision in its legal and procedural context, and then, after analyzing the Court’s opinion, considers the open questions that remain to be resolved through further activity in the Patent Office and in the lower courts.
Read the full article by clicking the link below.
Unanimous Supreme Court Refines the Scope of Patent-Inelligible Processes
The articles on our Web site include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice or as an expression of the views of the firm, its attorneys or any of its clients. We hope the articles spur discussion in the legal community with insight into the experience of the authors. We expressly reserve the right in the future to become wiser or simply change our mind.